Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2015PLoS ONEOpen Access

Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

RTRyoichi TanakaKyoto City HospitalMTMitsuhiro TomosugiKanazawa Medical UniversityMHMano HorinakaKyoto Prefectural University of Medicine

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tanaka et al. (2015) studied this question.

synapsesocial.com/papers/6ab32458fc5692df778944fchttps://doi.org/10.1371/journal.pone.0125779
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors1997 · 1,672 citations
  2. 2FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer2011 · 7,945 citations